References
- Hu B, Guo H, Zhou P, Shi Z-L. Characteristics of SARS-CoV-2 and COVID-19. Nat Rev Microbiol. 2020 Oct 6;1–14. ( Epub ahead of print). doi:https://doi.org/10.1038/s41579-020-00459-7.
- Mallah SI, Ghorab OK, Al-Salmi S, et al. COVID-19: breaking down a global health crisis. Ann Clin Microbiol Antimicrob. 2021;20:35. Published online. 2021 May 18. doi:https://doi.org/10.1186/s12941-021-00438-7.
- World Health Organization. Coronavirus (COVID-19) Dashboard. https://covid19.who.int/. Accessed August 9, 2021.
- Stephens-Davidowitz S. Google searches can help us find emerging Covid-19 outbreaks. The New York Times, April 5, 2020. https://www.nytimes.com/2020/04/05/opinion/coronavirus-google-searches.html. Accessed August 9, 2021.
- Sen M, Honavar SG, Sharma N, Sachdev MS. COVID-19 and eye: a review of ophthalmic manifestations of COVID-19. Indian J Ophthalmol. 2021;69(3):488–509. doi:https://doi.org/10.4103/ijo.IJO_297_21.
- La Distia Nora R, Putera I, Khalisha DF, Septiana I, Ridwan AS, Sitompul R. Are eyes the windows to COVID-19? Systematic review and meta-analysis. BMJ Open Ophthalmol. 2020 Sep 6;5(1):e000563. eCollection 2020 doi:https://doi.org/10.1136/bmjophth-2020-000563.
- Kumar KK, Sampritha UC, Prakash AA, et al. Ophthalmic manifestations in the COVID-19 clinical spectrum. Indian J Ophthalmol. 2021;69(3):691–694. doi:https://doi.org/10.4103/ijo.IJO_3037_20.
- Farvardin M, Johari M, Tahamtan M, et al. Ophthalmic manifestations of COVID-19; a less-appreciated yet significant challenge. Int Ophthalmol. 2021 Mar;41(3):1141–1147. Epub 2021 Jan 2. doi:https://doi.org/10.1007/s10792-020-01664-2
- Ho D, Low R, Tong L, Gupta V, Veeraraghavan A, Agrawal R. COVID-19 and the ocular surface: a review of transmission and manifestations. Ocul Immunol Inflamm. 2020;28(5):726–734. Epub 2020 Jun 16. doi:https://doi.org/10.1080/09273948.2020.1772313.
- Kennedy A, Shantha JG, Olivia LJP, et al. SARS-CoV-2 and the eye: implications for the retina specialist from human coronavirus outbreaks and animal models. J Vitreoretin Dis. 2020 Oct;4(5):411–419. Epub 2020 Jul 27. doi:https://doi.org/10.1177/2474126420939723.
- Seah I, Agrawal R. Can the coronavirus disease 2019 (COVID-19) affect the eyes? A review of coronaviruses and ocular implications in humans and animals. Ocul Immunol Inflamm. 2020;28(3):391–395. Epub 2020 Mar 16. doi:https://doi.org/10.1080/09273948.2020.1738501.
- Jevnikar K, Jaki Mekjavic P, Vidovic Valentincic N, Petrovski G, Globocnik Petrovic M. An update on COVID-19 related ophthalmic manifestations. Ocul Immunol Inflamm. 2021; 29(4): 684–689. doi:https://doi.org/10.1080/09273948.2021.1896008.
- Felfeli T, Mazzulli T, Clark ST, El-Defrawy SR, Chan CC. SARS-CoV-2 not detectable in ocular specimens of a patient with a past infection. Ocul Immunol Inflamm. 2021; 29(4): 681–683. doi:https://doi.org/10.1080/09273948.2021.1894458.
- Yagci BA, Atas F, Kaya M, Arikan G. COVID-19 associated bilateral acute iris transillumination. Ocul Immunol Inflamm. 2021; 29(4): 719–721. doi:https://doi.org/10.1080/09273948.2021.1933073.
- Uzun A, Keles Sahin A, Bektas O. A unique case of branch retinal artery occlusion associated with a relatively mild coronavirus disease 2019. Ocul Immunol Inflamm. 2021; 29(4): 715–718. doi:https://doi.org/10.1080/09273948.2021.1933071.
- Bapaye MM, Nair AG, Bapaye CM, Bapaye MM, Shukla JJ. Simultaneous bilateral central retinal artery occlusion following COVID-19 infection. Ocul Immunol Inflamm. 2021; 29(4): 671–674. doi:https://doi.org/10.1080/09273948.2021.1891262.
- Gonzalez-Lopez JJ, Felix Espinar B, Ye-Zhu C. Symptomatic retinal microangiopathy in a patient with coronavirus disease 2019 (COVID-19): single case report. Ocul Immunol Inflamm. 2021; 29(4): 642–644. doi:https://doi.org/10.1080/09273948.2020.1852260.
- Wang L, Deng Y. Comment on “ocular manifestations of hospitalized patients with COVID-19 in Northeast of Iran.” Ocul Immunol Inflamm. 2021; 29(4): 697. doi:https://doi.org/10.1080/09273948.2021.1903939.
- Abrishami M, Omidtabrizi A. Response to “comment on: ocular manifestations of hospitalized patients with COVID-19 in Northeast of Iran.” Ocul Immunol Inflamm. 2021; 29(4): 698–699. doi:https://doi.org/10.1080/09273948.2021.1903940.
- Marquezan MC, Marquezam JP, Nascimento H, Chalita MR, de Freitas D, Belfort R Jr. Conjunctivitis related to not severe COVID-19: a case report. Ocul Immunol Inflamm. 2021; 29(4): 631–633. doi:https://doi.org/10.1080/09273948.2020.1837186.
- Kocamış Ö, Örnek K, Aşıkgarip N, Hızmalı L, Sezgin FM, Şahin Y. Evaluation of Nasopharyngeal and Conjunctival Swab Samples of Hospitalised Patients with Confirmed COVID-19. Ocul Immunol Inflamm. 2021; 29(4): 634–637. doi:https://doi.org/10.1080/09273948.2020.1838558.
- Ciloglu E, Dogan NC, Ozdemir E, Kaya H, Cetinkaya PD. The presence of SARS-CoV-2 in conjunctival secretions of COVID-19 patients. Ocul Immunol Inflamm. 2021; 29(4): 652–655. doi:https://doi.org/10.1080/09273948.2020.1869270.
- Arora R, Goel R, Saxena S, et al. Comparative evaluation of tears and nasopharyngeal swab for SARS-CoV-2 in COVID-19 dedicated intensive care unit patients. Ocul Immunol Inflamm. 2021; 29(4): 690–696. doi:https://doi.org/10.1080/09273948.2021.1903938.
- Boz AAE, Atum M, Çakır B, Karabay O, Çelik E, Alagöz G. Outcomes of the ophthalmic examinations in patients infected by SARS-CoV-2. Ocul Immunol Inflamm. 2021; 29(4): 638–641. doi:https://doi.org/10.1080/09273948.2020.1844904.
- Lima LCF, Moraes Junior HV, Moraes HMV. COVID-19 ocular manifestations in the early phase of disease. Ocul Immunol Inflamm. 2021; 29(4): 666–668. doi:https://doi.org/10.1080/09273948.2021.1887278.
- Gunduz A, Ozturk E, Cagasar O. The impact of COVID-19 on conjunctival flora. Ocul Immunol Inflamm. 2021; 29(4): 709–714. doi:https://doi.org/10.1080/09273948.2021.1927118.
- Marinho PM, Marcos AAA, Branco AMC, et al. COVID-19 retinal findings in patients admitted to intensive care units and wards. Ocul Immunol Inflamm. 2021; 29(4): 705–708. doi:https://doi.org/10.1080/09273948.2021.1912362.
- Conrady CD, Faia LJ, Gregg KS, Rao RC. Coronavirus-19-associated retinopathy. Ocul Immunol Inflamm. 2021; 29(4): 675–676. doi:https://doi.org/10.1080/09273948.2021.1894456.
- Aşıkgarip N, Temel E, Hızmalı L, Örnek K, Sezgin FM. Retinal vessel diameter changes in COVID-19 infected patients. Ocul Immunol Inflamm. 2021 Jan; 29(4): 645–651. doi:https://doi.org/10.1080/09273948.2020.1853783.
- Sanjay S, Srinivasan P, Jayadev C, et al. Post COVID-19 ophthalmic manifestations in an Asian Indian male. Ocul Immunol Inflamm. 2021; 29(4): 656–661. doi:https://doi.org/10.1080/09273948.2020.1870147.
- Soni A, Narayanan R, Tyagi M, Belenje A, Basu S. Acute retinal necrosis as a presenting ophthalmic manifestation in COVID 19 recovered patients. Ocul Immunol Inflamm. 2021; 29(4): 722–725. doi:https://doi.org/10.1080/09273948.2021.1938135.
- Mangan MS, Yildiz E. New onset of unilateral orbital myositis following mild COVID-19 infection. Ocul Immunol Inflamm. 2021; 29(4): 669-670. doi:https://doi.org/10.1080/09273948.2021.1887282.
- Hosseini SM, Abrishami M, Zamani G, et al. Acute bilateral neuroretinitis and panuveitis in a patient with coronavirus disease 2019: a case report. Ocul Immunol Inflamm. 2021; 29(4): 677–680. doi:https://doi.org/10.1080/09273948.2021.1894457.
- Casagrande M, Fitzek A, Püschel K, et al. Detection of SARS-CoV-2 in human retinal biopsies of deceased COVID-19 patients. Ocul Immunol Inflamm. 2020 Jul 3;28(5):721–725. Epub 2020 May 29. doi:https://doi.org/10.1080/09273948.2020.1770301.
- Araujo-Silva CA, Marcos AAA, Marinho PM, et al. Presumed SARS-CoV-2 viral particles in the human retina of patients with COVID-19. JAMA Ophthalmol. 2021 Jul 29. Online ahead of print. doi:https://doi.org/10.1001/jamaophthalmol.2021.2795.
- Syed NA, Grose C. Identification of COVID-19 virus in human intraocular tissues. JAMA Ophthalmol. 2021 Jul 29. Online ahead of print. doi:https://doi.org/10.1001/jamaophthalmol.2021.2806.
- Crook H, Raza S, Nowell J, Young M, Edison P. Long covid-mechanisms, risk factors, and management. BMJ. 2021;374:n1648. doi:https://doi.org/10.1136/bmj.n1648.
- Proal AD, VanElzakker MB. Long COVID or post-acute sequelae of COVID-19 (PASC): an overview of biological factors that may contribute to persistent symptoms. Front Microbiol. Jun 23, 2021;12:698169. eCollection 2021. doi:https://doi.org/10.3389/fmicb.2021.698169.
- Phillips S, Williams MA. Confronting our next national health disaster - long-haul covid. N Engl J Med. 2021;385(7):577–579. doi:https://doi.org/10.1056/NEJMp2109285.